Position in STIM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$30,174
-$119,153 QoQ
Shares Held
23,211
-78.5% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 86 holders
Holding Since
Jun 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STIM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $1,102,778,563 across 42 Medical Devices names. STIM ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
8,943,771 | $381,720,146 | |
| 2 | MDT |
Medtronic plc
|
2,770,165 | $216,710,007 | |
| 3 | ABT |
Abbott Laboratories
|
2,141,915 | $194,357,367 | |
| 4 | PODD |
Insulet Corp
|
663,968 | $101,089,128 | |
| 5 | STE |
STERIS plc
|
188,020 | $39,591,371 | |
| 6 | EW |
Edwards Lifesciences Corp
|
414,438 | $37,490,061 | |
| 7 | IRTC |
iRhythm Holdings, Inc.
|
271,624 | $32,309,674 | |
| 8 | IRMD |
Iradimed Corp
|
157,199 | $15,021,936 |
All Filings in STIM
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,174 | 23,211 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $149,327 | 108,208 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $86,949 | 24,914 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $258,851 | 70,340 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $204 | 114 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $40,698 | 8,550 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $330 | 114 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $153 | 114 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $167,998 | 24,454 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $63,596 | 19,999 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $72,818 | 22,685 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||